Tarceva
NDC 54868-5447
Product Information
Tarceva is a NDA-approved product labeled by Physicians Total Care, Inc.. Erlotinib is used to treat lung and pancreatic cancer. It is supplied as a white product. This product entry covers the primary NDC 54868-5447 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
9 MM
10 MM
T;25
T;100
T;150
Code Structure Chart
Product Details
What is NDC 54868-5447?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ERLOTINIB HYDROCHLORIDE (UNII: DA87705X9K)
- ERLOTINIB (UNII: J4T82NDH7E) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
- HYPROMELLOSES (UNII: 3NXW29V3WO)
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- SODIUM LAURYL SULFATE (UNII: 368GB5141J)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1088251 - Tarceva 100 MG Oral Tablet
- RxCUI: 1088251 - erlotinib 100 MG Oral Tablet [Tarceva]
- RxCUI: 1088253 - Tarceva 150 MG Oral Tablet
- RxCUI: 1088253 - erlotinib 150 MG Oral Tablet [Tarceva]
- RxCUI: 1088255 - Tarceva 25 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.